title: Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
abstract: BACKGROUND
  Conversion of sputum mycobacterial cultures from positive growth to negative growth of Mycobacterium tuberculosis in patients with pulmonary tuberculosis (TB) is considered the most important interim indicator of the efficacy of anti-TB pharmacologic treatment for multidrug-resistant disease.
  
  
  OBJECTIVE
  To evaluate and compare time to and predictors of initial sputum culture conversion with predictors of treatment outcome for patients with multidrug-resistant TB.
  
  
  METHODS
  Retrospective cohort study.
  
  
  METHODS
  Latvia.
  
  
  METHODS
  All civilian patients with multidrug-resistant TB treated with the DOTS-Plus strategy between 1 January and 31 December 2000.
  
  
  METHODS
  Individualized treatment for confirmed sputum culture-positive pulmonary multidrug-resistant TB.
  
  
  METHODS
  Time to initial sputum culture conversion and treatment outcome.
  
  
  RESULTS
  Among 167 patients who were sputum culture-positive at initiation of second-line therapy, 129 (77%) converted in a median time of 60 days (range, 4 to 462 days) and 38 (23%) did not convert. Independent predictors of a longer sputum culture conversion time, using an accelerated failure time regression model, included previous treatment for multidrug-resistant TB, high initial sputum culture colony count, bilateral cavitations on chest radiography, and the number of drugs the initial isolate was resistant to at treatment initiation. Treatment outcomes were statistically significantly worse for patients who did not convert their sputum culture within 2 months.
  
  
  CONCLUSIONS
  Twenty-five percent of patients missed 5 or more monthly sputum collections.
  
  
  CONCLUSIONS
  Under program conditions in Latvia, most patients with multidrug-resistant TB achieved sputum culture conversion within 12 weeks of starting treatment. Chest radiography and sputum culture drug susceptibility testing can assist physicians in predicting which patients will convert more slowly. Sputum culture conversion is a useful and appropriate interim indicator of treatment outcome in patients with multidrug-resistant TB.
authors: Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. tholtz@cdc.gov
authors: Timothy H
authors: TH
authors: Holtz
authors: Maya
authors: M
authors: Sternberg
authors: Steve
authors: S
authors: Kammerer
authors: Kayla F
authors: KF
authors: Laserson
authors: Vija
authors: V
authors: Riekstina
authors: Evija
authors: E
authors: Zarovska
authors: Vija
authors: V
authors: Skripconoka
authors: Charles D
authors: CD
authors: Wells
authors: Vaira
authors: V
authors: Leimane